Search research articles
Contact Us
Filters
Showing results (381-390 of 427) with videos related to
Page
of 43
Sort By:
Nature
|
December 24, 2010
Cortical representations of olfactory input by trans-synaptic tracing
Kazunari Miyamichi, Fernando Amat, Farshid Moussavi, et al.
British Journal of Haematology
|
September 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm
Michal Nordkin, Nashwa Fadaos, Ronit Leiba, et al.
Human Gene Therapy
|
October 6, 1998
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
M Schuler, C Rochlitz, J A Horowitz, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 16, 2012
Chemokines in bipolar disorder: trait or state?
Izabela Guimarães Barbosa, Natália Pessoa Rocha, Moisés Evandro Bauer, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab
Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Optics Express
|
January 7, 2017
Single-shot terahertz time-domain spectroscopy in pulsed high magnetic fields
G Timothy Noe, Ikufumi Katayama, Fumiya Katsutani, et al.
Cancer Gene Therapy
|
August 6, 2005
Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial
I A Atencio, M Grace, R Bordens, et al.
Vaccines
|
October 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, et al.
Antibodies (Basel, Switzerland)
|
August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 427) with videos related to
Sort By:
Page
of 43
Nature
|
December 24, 2010
Cortical representations of olfactory input by trans-synaptic tracing
Kazunari Miyamichi, Fernando Amat, Farshid Moussavi, et al.
British Journal of Haematology
|
September 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm
Michal Nordkin, Nashwa Fadaos, Ronit Leiba, et al.
Human Gene Therapy
|
October 6, 1998
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
M Schuler, C Rochlitz, J A Horowitz, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 16, 2012
Chemokines in bipolar disorder: trait or state?
Izabela Guimarães Barbosa, Natália Pessoa Rocha, Moisés Evandro Bauer, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab
Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Optics Express
|
January 7, 2017
Single-shot terahertz time-domain spectroscopy in pulsed high magnetic fields
G Timothy Noe, Ikufumi Katayama, Fumiya Katsutani, et al.
Cancer Gene Therapy
|
August 6, 2005
Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial
I A Atencio, M Grace, R Bordens, et al.
Vaccines
|
October 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, et al.
Antibodies (Basel, Switzerland)
|
August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Page
of 43